CONWAY ROBERT E
Insider CIK 1184334 · NVLS Director · ABIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 10,000 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 17,500 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 7,650 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 1,912 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 3,075 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer deriv | 2024-05-20 | 2024-05-20 | 2,868 | — | $0 | 0 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | D To issuer | 2024-05-20 | 2024-05-20 | 50,000 | — | $0 | 0 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2024-01-30 | 2024-01-31 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2024-01-02 | 2024-01-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2022-12-15 | 2022-12-19 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2022-01-03 | 2022-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | S Sale | 2021-09-23 | 2021-09-24 | 15,000 | $10.08 | $151.2K | 50,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2021-09-23 | 2021-09-27 | 15,000 | $10.08 | $151.2K | 50,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2021-09-21 | 2021-09-23 | 10,000 | $9.80 | $98.0K | 35,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2021-05-12 | 2021-05-13 | 10,000 | $3.19 | $31.9K | 50,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2021-05-05 | 2021-05-06 | 10,000 | $3.23 | $32.3K | 40,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2021-01-12 | 2021-01-13 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2021-01-04 | 2021-01-05 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2020-12-18 | 2020-12-21 | 10,000 | $4.16 | $41.6K | 30,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | P Buy | 2020-11-19 | 2020-11-23 | 10,000 | $8.03 | $80.3K | 25,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2020-09-25 | 2020-09-25 | 5,000 | $4.28 | $21.4K | 20,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2020-09-22 | 2020-09-24 | 3,056 | $4.66 | $14.2K | 15,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2020-09-21 | 2020-09-21 | 10,000 | $4.77 | $47.7K | 11,944 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2020-01-02 | 2020-01-06 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2019-01-02 | 2019-01-04 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ALPN ALPINE IMMUNE SCIENCES, IN | A Award deriv | 2018-01-02 | 2018-01-04 | 7,650 | — | $0 | 7,650 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2017-07-14 | 2017-07-17 | 10,000 | $2.49 | $24.9K | 35,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2017-05-09 | 2017-05-10 | 5,000 | $2.34 | $11.7K | 45,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2017-05-08 | 2017-05-11 | 15,000 | $2.28 | $34.2K | 60,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2017-05-05 | 2017-05-09 | 20,000 | $2.30 | $46.0K | 40,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2017-05-04 | 2017-05-08 | 10,000 | $2.26 | $22.6K | 20,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | P Buy | 2017-03-24 | 2017-03-27 | 25,000 | $2.59 | $64.8K | 25,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2017-02-16 | 2017-02-21 | 8,000 | — | $0 | 8,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2016-09-12 | 2016-09-14 | 12,300 | — | $0 | 12,300 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2016-02-11 | 2016-02-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2015-12-09 | 2015-12-11 | 10,000 | $8.10 | $81.0K | 10,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2015-09-11 | 2015-09-15 | 7,650 | — | $0 | 7,650 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2015-07-16 | 2015-07-20 | 11,475 | — | $0 | 11,475 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2015-02-12 | 2015-02-17 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2014-02-11 | 2014-02-13 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2013-09-17 | 2013-09-19 | 14,750 | — | $0 | 14,750 | SEC↗ |
| ABIO ARCA biopharma, Inc. | A Award deriv | 2013-09-17 | 2013-09-19 | 2,608 | — | $0 | 2,608 | SEC↗ |